Progesterone therapy, usually oral micronized progesterone or a prescribed progestin, protects the uterine lining when taken alongside estrogen and can support sleep and menstrual regulation. It carries specific contraindications, including active blood clots, certain cancers, and pregnancy, which is why clinician oversight matters before starting treatment.
TL;DR:
- Most women will experience drowsiness after taking oral micronized progesterone, which is why it is typically taken at bedtime.
- The main validated benefit of progesterone therapy is its ability to protect the uterine lining when combined with estrogen to reduce endometrial cancer risk.
- Contraindications include active blood clots, certain cancers, liver issues, pregnancy, and peanut oil allergy, requiring careful screening before use.
- Evidence suggests progesterone may improve sleep and perceived night sweats, but it has limited impact on hot flash scores according to recent trials.
- Delivery methods like vaginal or transdermal routes offer alternatives that can target specific uses and modify systemic risk profiles.
Table of Contents
- What progesterone is and how it works
- Conditions and uses supported by evidence
- Benefits readers can expect
- Risks, side effects, and absolute contraindications
- Delivery methods and typical dosing
- Progesterone versus progestin: what it means for you
- Evidence summary: FDA labeling, trials, and clinical guidance
- Who is a candidate and what treatment looks like
- Where the conventional advice on progesterone gets it wrong
- Getting progesterone therapy safely and with real oversight
- Sources
- FAQ
What progesterone is and how it works
Progesterone is the hormone that rises after ovulation and prepares the uterine lining for a possible pregnancy, then falls if pregnancy doesn't occur, triggering a period. When used as therapy, it comes in two distinct forms that behave differently in the body.
- Micronized progesterone is chemically identical to the hormone the body produces, processed into tiny particles so it absorbs reliably when swallowed.
- Synthetic progestins, like medroxyprogesterone acetate, are lab-made molecules that act on the same receptors but also affect androgen and glucocorticoid receptors, which changes their side effect profile.
- Because progesterone is fat-soluble, it needs an oil suspension and micronization to absorb consistently, and it's typically dosed at bedtime because it causes drowsiness, a point covered in the pharmacology of oral micronized progesterone.
The distinction between bioidentical progesterone and progestins isn't cosmetic. It shapes tolerability, metabolic effects, and how a clinician builds a hormone regimen, a topic explored further in estrogen versus progesterone.
Conditions and uses supported by evidence
Progesterone therapy addresses a specific set of clinical needs, though the strength of evidence varies by use.
- Endometrial protection: Anyone with a uterus taking systemic estrogen needs a progestogen to reduce the risk of endometrial cancer, according to ACOG guidance on hormone therapy.
- Secondary amenorrhea: Oral micronized progesterone is FDA-labeled to induce a period in women who have stopped menstruating without an anatomical cause.
- Perimenopausal sleep and night sweats: A Phase III randomized trial found no statistically significant improvement in the primary hot flash score, but participants reported perceived improvements in night sweats and sleep.
- Fertility and luteal support: Progesterone is used in some fertility protocols to support the uterine lining, though evidence for benefit varies by clinical context and should be guided by a fertility specialist.
- Preterm birth prevention: Following the withdrawal of 17-OHPC (Makena), ACOG's updated practice advisory calls for individualized discussion of vaginal progesterone and other options.
Benefits readers can expect
The clearest, best-supported benefit is endometrial protection. When oral micronized progesterone is paired with systemic estrogen, it counters estrogen's stimulating effect on the uterine lining, a use with solid regulatory backing.
- Endometrial safety: Progestogen use alongside estrogen is standard practice specifically to limit endometrial cancer risk, per ACOG.
- Sleep and night sweats: Bedtime dosing appears to help some women feel they sleep better and sweat less at night, even when objective hot flash scores don't move as much.
- Cycle regulation: FDA-labeled regimens reliably induce withdrawal bleeding in secondary amenorrhea.
- Metabolic profile: A comprehensive review found that micronized progesterone tends to be better tolerated than some synthetic gestagens, with less adverse impact on lipids and glucose metabolism.
A Phase III trial of 300 mg oral micronized progesterone found no statistically significant reduction in the primary vasomotor symptom score at three months, despite participants reporting improved sleep and fewer perceived night sweats, a distinction worth raising with a prescriber, per the same RCT. That gap between how women feel and what the primary trial endpoint measured is one reason expectations matter as much as the prescription itself.
Risks, side effects, and absolute contraindications
Most people tolerate progesterone therapy reasonably well, but side effects are common enough to plan for, and a smaller set of contraindications rule it out entirely.
- Common side effects: drowsiness, dizziness, breast tenderness, bloating, and nausea, most pronounced in the hours after a dose.
- Serious risk signals: FDA labeling for PROMETRIUM carries boxed warning language tied to Women's Health Initiative findings of increased blood clots, stroke, and heart attack risk with combined estrogen and progestin therapy, particularly in older postmenopausal women, and it recommends the lowest effective dose for the shortest duration.
- Absolute contraindications: active or prior blood clots (VTE/PE), active breast cancer, active arterial clotting disease, liver dysfunction, pregnancy, and known allergy to formulation ingredients such as peanut oil, which some oral capsules use as a suspension base.
- Action step: sudden leg swelling, chest pain, vision changes, or severe headache after starting therapy warrants urgent medical attention, not a wait-and-see approach.
Pro Tip: Take oral progesterone at bedtime and skip driving or operating machinery for a few hours after your first dose, since the soporific effect varies from person to person.
Delivery methods and typical dosing
Route matters almost as much as the hormone itself, since it changes both effectiveness and side effect risk.
- Oral micronized progesterone for endometrial protection: FDA labeling for PROMETRIUM specifies a typical dose taken at bedtime for about two weeks per monthly cycle.
- Oral micronized progesterone for secondary amenorrhea: the same labeling specifies a higher single bedtime dose taken for approximately 10 days.
- Bedtime dosing rationale: progesterone's drowsiness effect is predictable enough that clinicians build it into the regimen rather than treat it as an unexpected side effect.
- Vaginal progesterone: chosen when a more localized effect is wanted, including certain pregnancy-related applications, since it bypasses some of the systemic absorption issues of oral dosing.
- Transdermal and IUD-delivered progestins: these routes distribute the hormone differently through the body, which is part of why a hormonal IUD's systemic risk profile differs from an oral progestin's.
Progesterone versus progestin: what it means for you
The choice between bioidentical progesterone and a synthetic progestin isn't just a formulation detail. It affects how the hormone interacts with receptors beyond the uterus.
- Receptor selectivity: Micronized progesterone binds mainly to progesterone receptors, while many progestins also interact with androgen or glucocorticoid receptors, producing different side effects.
- Evidence signals: Some cohort and clinical trial literature suggests differences between progesterone and certain progestins in thromboembolism and breast tissue effects, though findings vary by study design and population.
- Practical implication: a clinician weighs a patient's personal risk factors, whether that's a family history of clotting or a preference for a gentler metabolic profile, before recommending one formulation over another, as discussed further in estrogen versus progesterone.
Evidence summary: FDA labeling, trials, and clinical guidance
The core evidence base behind progesterone therapy comes from four sources: FDA drug labeling, a landmark tolerability review, a recent randomized trial, and ACOG's clinical guidance.
| Source | What it establishes |
|---|---|
| FDA PROMETRIUM labeling | Dosing: 200 mg x 12 days per 28-day cycle for endometrial protection; 400 mg x 10 days for secondary amenorrhea |
| FDA boxed warning label | Increased VTE, stroke, and MI risk with combined estrogen and progestin therapy per WHI data |
| Micronized progesterone review | Endometrial protection with favorable lipid and glucose profile versus some synthetic progestins |
| Phase III perimenopause RCT | 300 mg nightly dose: no significant primary VMS improvement, but perceived sleep and night sweat benefit |
| ACOG hormone therapy guidance | Progestogen required with systemic estrogen in women with a uterus; outlines cyclic vs continuous regimens |
Together, these sources describe a therapy with clear regulatory dosing, a documented cardiovascular risk profile in combined regimens, and mixed but promising trial data on symptom relief.
Who is a candidate and what treatment looks like
A candidate evaluation starts with history, not a prescription pad.
- History review: personal and family history of blood clots, breast cancer, liver disease, and any known allergy to peanut oil or other capsule excipients, as noted in older PROMETRIUM labeling.
- Baseline labs: bloodwork tailored to the individual's risk factors and treatment goals rather than a fixed panel for everyone.
- Monitoring: routine estradiol level testing generally isn't recommended for hormone therapy follow-up per ACOG guidance; monitoring instead focuses on symptoms and bleeding patterns.
- Timeline: sleep and bleeding pattern changes often show up within one or two cycles, while vasomotor symptom relief can take longer and may need dose or route adjustment.
Pro Tip: Keep a simple symptom log for the first two cycles. It gives your clinician real data to titrate dose or switch route instead of guessing.
Where the conventional advice on progesterone gets it wrong
The popular narrative treats progesterone as either a cure-all for perimenopause or a hormone to avoid because of the Women's Health Initiative's warnings, though some seek menopause support with Black Cohosh as complementary symptom relief. Both framings miss the point. The WHI data that drives most of the fear was about combined estrogen and synthetic progestin, in an older population, not a blanket statement about micronized progesterone in a 45-year-old starting therapy for sleep and irregular cycles.
At the same time, the wellness industry oversells progesterone's mood and vasomotor benefits based on how patients feel rather than what randomized trials actually measure. The 2023 Phase III trial is a useful correction: participants felt better, but the primary symptom score didn't move significantly. That gap between perception and measurement doesn't mean the hormone is useless. It means the honest answer is "it may help, and here's what we don't know yet," not a marketing promise dressed up as science.
— Organic
Getting progesterone therapy safely and with real oversight
If you're weighing progesterone therapy, the safest path is working with a clinician who reviews your history, orders the right labs, and adjusts your regimen instead of guessing at a dose. Some providers offer physician-supervised hormone replacement therapy built around that process, using FDA-regulated formulations rather than unverified compounded products.
- A Doctor's Consultation starts with a full history review, including the contraindications that matter most for progesterone: clotting history, liver disease, and cancer history.
- The Signature HRT Membership bundles ongoing clinician oversight and prescription management for women pursuing hormone therapy.
- Women's Essential lab panels give you baseline bloodwork before starting therapy, which supports safer dosing decisions from day one.
If you want to discuss whether progesterone fits your symptoms and history, book a consultation and get a plan built around your labs, not a generic regimen.
Sources
This article draws on FDA prescribing information, ACOG's hormone therapy guidance, a Phase III randomized trial, and a peer-reviewed tolerability review, linked throughout the sections above.
This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.
- PROMETRIUM (progesterone) FDA prescribing information (DailyMed)
- PROMETRIUM prescribing information (FDA accessdata)
- Progesterone in peri- and postmenopause: a review (PMC)
- Oral micronized progesterone for perimenopausal night sweats and hot flushes: Phase III RCT (Scientific Reports / Nature)
- Hormone therapy for menopause (ACOG FAQ)
FAQ
What happens when a woman starts taking progesterone?
Most women notice drowsiness within hours of an oral dose, which is why it's typically taken at bedtime. Cycle regulation or withdrawal bleeding often follows within the first one to two treatment cycles, depending on the regimen prescribed.
Why are doctors hesitant to prescribe progesterone?
Some hesitation traces back to Women's Health Initiative findings on combined estrogen and synthetic progestin therapy, which showed increased risks of blood clots, stroke, and heart attack in older postmenopausal women, per FDA labeling. Clinicians weigh those risks against a patient's individual history before prescribing, which can slow the process.
What are the cons of taking progesterone?
Common downsides include drowsiness, dizziness, breast tenderness, and nausea, and it carries absolute contraindications including active blood clots, certain cancers, liver disease, and pregnancy. It also requires ingredient screening, since some oral capsules use peanut oil as a suspension base.
Is progesterone hormone therapy safe?
Oral micronized progesterone is FDA-approved with labeled dosing for specific indications, and a review of the evidence finds it generally well tolerated with a favorable metabolic profile compared with some synthetic progestins. Safety depends heavily on individual risk factors, which is why screening for contraindications before starting therapy matters.